Myocardial Metabolism
Showing 1 - 25 of >10,000
Ischemic Heart Disease (IHD) Trial in Tianjin (XTR003)
Completed
- Ischemic Heart Disease (IHD)
-
Tianjin, Tianjin, ChinaTEDA International Cardiovascular Hospital
May 23, 2023
Lipid Disorder, Premature Myocardial Infarction Trial in Harbin (No intervention)
Enrolling by invitation
- Lipid Disorder
- Premature Myocardial Infarction
- No intervention
-
Harbin, Heilongjiang, Chinathe first affiliated hospital of Harbin medical university
Dec 2, 2022
Acute Myocardial Infarction, Glucose Metabolism Disorders Trial in Beijing (Pitavastatin, Atorvastatin)
Recruiting
- Acute Myocardial Infarction
- Glucose Metabolism Disorders
-
Beijing, Beijing, ChinaFuwai Hospital
May 7, 2022
Sex and Obesity: Effects on Heart Failure Study
Active, not recruiting
- Obesity
- Heart Failure
- PET (positron Emission Tomography)
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 30, 2023
Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)
Completed
- Type2 Diabetes Mellitus
- Empagliflozin
- Placebo Oral Tablet
-
Herlev, DenmarkHerlev og Gentofte Hospital
Aug 17, 2022
Lipid Metabolism, Cardiovascular Diseases Trial in Shenzhen (PCSK9 inhibitor)
Recruiting
- Lipid Metabolism
- Cardiovascular Diseases
- PCSK9 inhibitor
-
Shenzhen, Guangdong, ChinaTangzhiming Li
May 4, 2022
Type 2 Diabetes, Diabetic Cardiomyopathies, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Oxford (IMB-1018972)
Recruiting
- Type 2 Diabetes
- +2 more
-
Oxford, United KingdomOxford University Hospital
Jan 9, 2023
Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)
Enrolling by invitation
- Heart Diseases
- +9 more
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 24, 2022
Heart Failure, Diastolic, Diastolic Heart Failure, Hypertension Trial in Nashville (regadenoson)
Completed
- Heart Failure, Diastolic
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 1, 2021
Myocardial Insulin Sensitivity, Impaired Glucose Metabolism, Diastolic Dysfunction Trial in Maastricht (Ciprofibrate 100Mg
Completed
- Myocardial Insulin Sensitivity
- +2 more
- Ciprofibrate 100Mg Tablet
- Placebo Oral Tablet
-
Maastricht, Limburg, NetherlandsNutrition and Movement Sciences
Jan 7, 2021
Type2 Diabetes, Polycystic Ovary Syndrome Trial in Shanghai
Recruiting
- Type2 Diabetes
- Polycystic Ovary Syndrome
-
Shanghai, Shanghai, ChinaRenji Hospital Department of Endocrinology and Metabolism
Mar 16, 2021
Metabolic Preparation, Myocardial Inflammation Trial in Monaco
Completed
- Metabolic Preparation
- Myocardial Inflammation
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Nov 6, 2020
'Prognostic Value of Hyperpolarized 13C MRI for Clinical
Not yet recruiting
- Ventricular Function, Left
- Myocardial Perfusion Imaging
- (no location specified)
Sep 13, 2023
Bosentan in Myocardium Metabolism and Perfusion Measured by
Terminated
- Myocardial Dysfunction
- Endothelial Dysfunction
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois
Mar 18, 2020
Heart Failure, Obstructive Sleep Apnea, Central Sleep Apnea Trial in Ottawa ([C11]Acetate and HED PET)
Active, not recruiting
- Heart Failure
- +2 more
- [C11]Acetate and HED PET
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Oct 11, 2022
Evaluation of Early Signs of Myocardial Injury After Thoracic
Recruiting
- Lung Non-Small Cell Carcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 6, 2023
Myocardial Infarction Trial in Spain (Calcifediol, Placebo)
Active, not recruiting
- Myocardial Infarction
- Calcifediol
- Placebo
-
Fuenlabrada, Madrid, Spain
- +6 more
Aug 26, 2022
Left Ventricular Dyssynchrony, Heart Failure, Left Bundle Branch Block Trial in Leuven, Oslo (Cardiac resynchronisation therapy,
Active, not recruiting
- Left Ventricular Dyssynchrony
- +3 more
- Cardiac resynchronisation therapy
- +3 more
-
Leuven, Belgium
- +1 more
Jan 7, 2020
Cardiac Disease, Cardiac Rehabilitation Trial (Thermotherapy)
Not yet recruiting
- Cardiac Disease
- Cardiac Rehabilitation
- Thermotherapy
- (no location specified)
Feb 13, 2023
Cardiovascular Diseases Trial in Peking (cardiomyopeptidin)
Active, not recruiting
- Cardiovascular Diseases
-
Peking, Beijing, ChinaChinese People's Liberation Army General Hospital
Dec 1, 2023
Heart Failure, Reduced Ejection Fraction Trial in Paris (Dapagliflozin)
Recruiting
- Heart Failure
- Reduced Ejection Fraction
-
Paris, FrancePitié-Salpêtrière Hospital
Dec 7, 2022
Aortic Valve Stenosis Trial in Oxford (Fenofibrate Capsules, Placental Lactogen)
Active, not recruiting
- Aortic Valve Stenosis
- Fenofibrate Capsules
- Placental Lactogen
-
Oxford, United KingdomOUH NHS trust
Feb 15, 2022
Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic
Recruiting
- Ischemic Heart Disease
- 13C-enriched pyruvate
-
Aarhus, Region Midtjylland, DenmarkAarhus University Hospital
Sep 20, 2023
Healthy Subjects, Cardiovascular Disease Trial (18F-FDG, 11C-butanol)
Not yet recruiting
- Healthy Subjects
- Cardiovascular Disease
- (no location specified)
Aug 22, 2023
Heart Failure, Obesity, Type 2 Diabetes Trial in Saint Louis ([18F]FluorbetaOx)
Completed
- Heart Failure
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 21, 2020